IND (Investigational New Drug) for DPX-0907 accepted by FDA
Scale Up - Successfully manufactured a pilot clinical batch of DPX-0907 at scale at cGMP site
CRO - Selected Cato Research to manage Phase 1 clinical trial for DPX-0907
Licensed our vaccine deliver technology to Pfizer Animal Health
Winner of Canada’s Top 10 Life Sciences Companies chosen by an independent expert panel of Canadian & U.S. venture capitalists